Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adaptive Platform Treatment Trial for Outpatients With COVID-19 (Adapt Out COVID)

NCT04518410 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.

NCT NCT04518410
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04518410 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adaptive Platform Treatment Trial for Outpatients With COVID-19 (Adapt Out COVID)
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Phase
Phase 2/3
Overall status
Completed
Start date
August 19, 2020
Completion date
June 20, 2023
Enrollment
4,044 (actual)
Sites
252

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus, covid19